HONG KONG – Some outward-looking Indian drugmakers may be benefiting from the cheapest rupee ever, but others, which hedged their currency bets, could take a hit.

HONG KONG – Some outward-looking Indian drugmakers may be benefiting from the cheapest rupee ever, but others, which hedged their currency bets, could take a hit.

HONG KONG – China-based Hansoh Pharmaceutical Group Co. Ltd. filed for an IPO in Hong Kong late last week, making it the 11th biopharma company to seek a listing on the Hong Kong Stock Exchange (HKEX) since May and following Ascentage Pharma Group International's IPO a week earlier.

HONG KONG – Fiscal year 2017 was good for most Chinese pharmaceutical companies, with mainland-listed pharma shares gaining 11 percent in value.

HONG KONG – Fiscal year 2017 was good for most Chinese pharmaceutical companies, with mainland-listed pharma shares gaining 11 percent in value.

HONG KONG – Hong Kong Exchanges and Clearing (HKEX) has revised its IPO rules to allow not-yet-profitable biotech companies go public in the city. That is likely to revive the biotechnology sector in Hong Kong's stock market, which hasn't attracted much interest in the past decade.